APL and covid-19


APL follows the development of the covid-19 carefully. We also follow FHM:s recommendations.

We have routines regarding reserves in the event of major production disruptions and we have created a priority list regarding the manufacture of extemporaneous medicines and important contracted medical products.

The company management team has carried out a competence inventory to identify what resources are available within the company, something that can strengthen production and production if necessary.

The ability to quickly modify production and manufacturing

We follow the demand for our products very closely, so that we can as quickly as possible identify possible deviations from previous patterns and quickly adapt our production accordingly. Our production manager and our assortment group have a special focus on this.

Other measures

  • We keep a safe distance, good hand hygiene and use mouth guards and rubbing alcohol when needed
  • We continue to keep our distance in public spaces
  • We use digital meetings as a first choice
  • We stay at home if we feel symptoms

Do you have questions about how APL handles covid-19?

Contact info@apl.se


Extemporeläkemedel och lagerberedningar

Beställ online via EbEx


Telefon: 010-447 97 00
e-post: kundservice@apl.se


Ordinarie öppettider:
Helgfria vardagar 08:00-17:00.


Öppettider sommar:
Helgfria vardagar 08:00-16:00.

Gäller 24 juni-16 augusti 2024.



Reservrutinen används endast för akuta medicinskt viktiga beställningar av extemporeläkemedel under tiden EbEx ordersystem inte kan nås. För att kunna använda dig av rutinen så krävs det att du redan är befintlig kund hos APL och har ett kundnummer.

Beställningar görs på för ändamålet avsedd blankett och får inte innehålla några patientuppgifter.

Beställningen skickas via e-post till kundservice@apl.se.



Visiting adress:

Prismavägen 2, Kungens Kurva

+46 10 447 96 00

Other contact information

About APL

Apotek Produktion & Laboratorier (APL) is one of Europe’s leading companies manufacturing extemporaneous drugs and stock preparations. We have a public policy assignment from the Swedish government, but also work together with other pharmaceutical companies to create the greatest possible patient benefit. The assignment also comprises preparedness to maintain operations in times of crisis and ultimately war.

Our vision is that we will make a difference for patients with additional needs. We are also an established contract manufacturer within life science in Scandinavia, where we deliver services within development and analysis. With more than 500 employees and five manufacturing units in Malmö, Gothenburg, Stockholm and Umeå, we develop drugs that improve and save lives.

Read more